Literature DB >> 15875250

A new way of incorporating silicon in hydroxyapatite (Si-HA) as thin films.

E S Thian1, J Huang, S M Best, Z H Barber, W Bonfield.   

Abstract

Bioactive silicon-containing hydroxyapatite (Si-HA) thin films that can be used as coatings for bone tissue replacement have been developed. A magnetron co-sputtering technique was used to deposit Si-HA films up to 700 nm thick on titanium substrates, with a silicon level up to 1.2 wt%. X-ray diffraction demonstrated that annealing transformed the as-deposited Si-HA films which were amorphous, into a crystalline HA structure. A human osteoblast-like (HOB) cell model was used to determine the biocompatibility of these films. HOB cells were seen to attach and grow well on the Si-HA films, and the metabolic activity of HOB cells on these films was observed to increase with culture time. Furthermore, mineralisation of the cell layers was observed after 8 weeks of culture. Based on the present findings, Si-HA of different film compositions demonstrate bioactive properties in-vitro, and indicate the potential as biocoatings for a wide variety of medical implants including load-bearing applications such as the femoral stem of hip replacement implants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15875250     DOI: 10.1007/s10856-005-6980-9

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  17 in total

1.  Growth-promoting effects of silicon in rats.

Authors:  K Schwarz; D B Milne
Journal:  Nature       Date:  1972-10-06       Impact factor: 49.962

2.  Effect of hydroxyapatite thickness on metal ion release from Ti6Al4V substrates.

Authors:  S R Sousa; M A Barbosa
Journal:  Biomaterials       Date:  1996-02       Impact factor: 12.479

3.  Structural changes of thermally sprayed hydroxyapatite investigated by Rietveld analysis.

Authors:  J C Knowles; K Gross; C C Berndt; W Bonfield
Journal:  Biomaterials       Date:  1996-03       Impact factor: 12.479

4.  Plasma sprayed coatings of hydroxylapatite.

Authors:  K de Groot; R Geesink; C P Klein; P Serekian
Journal:  J Biomed Mater Res       Date:  1987-12

5.  Application of magnetron sputtering for producing ceramic coatings on implant materials.

Authors:  J A Jansen; J G Wolke; S Swann; J P Van der Waerden; K de Groot
Journal:  Clin Oral Implants Res       Date:  1993-03       Impact factor: 5.977

Review 6.  Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: a review.

Authors:  L Sun; C C Berndt; K A Gross; A Kucuk
Journal:  J Biomed Mater Res       Date:  2001

7.  In vitro mechanical and biological assessment of hydroxyapatite-reinforced polyethylene composite.

Authors:  J Huang; L Di Silvio; M Wang; K E Tanner; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

8.  In vivo tensile testing of fluorapatite and hydroxylapatite plasma-sprayed coatings.

Authors:  I M Kangasniemi; C C Verheyen; E A van der Velde; K de Groot
Journal:  J Biomed Mater Res       Date:  1994-05

9.  Silicon: a possible factor in bone calcification.

Authors:  E M Carlisle
Journal:  Science       Date:  1970-01-16       Impact factor: 47.728

10.  Silicon: an essential element for the chick.

Authors:  E M Carlisle
Journal:  Science       Date:  1972-11-10       Impact factor: 47.728

View more
  3 in total

1.  Novel deposition of nano-sized silicon substituted hydroxyapatite by electrostatic spraying.

Authors:  J Huang; S N Jayasinghe; S M Best; M J Edirisinghe; R A Brooks; N Rushton; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  2005-12       Impact factor: 3.896

2.  Interfacial titanium oxide between hydroxyapatite and TiAlFe substrate.

Authors:  Valentin Nelea; Constantin Morosanu; Mircea Bercu; Ion N Mihailescu
Journal:  J Mater Sci Mater Med       Date:  2007-06-14       Impact factor: 3.896

3.  Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial.

Authors:  Tim D Spector; Mario R Calomme; Simon H Anderson; Gail Clement; Liisa Bevan; Nathalie Demeester; Rami Swaminathan; Ravin Jugdaohsingh; Dirk A Vanden Berghe; Jonathan J Powell
Journal:  BMC Musculoskelet Disord       Date:  2008-06-11       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.